Skip to content

Circular RNA Translation Modulation via Small Ligand-Mediated Protein Stabilization.

Aug 2026 · Analytical Chemistry · Vol 98 32, pp. 23819-23826 · 0 citations · 27 references
Medicine

TL;DR

A new chemically regulated circRNA translation system based on small ligand-induced stabilization of RNA-binding proteins (RBPs), engineered by incorporating RNA motifs into an internal ribosomal entry site and fusing RBPs with small ligand-stabilized conditional proteins is developed.

Abstract

Circular RNAs (circRNAs) have emerged as a promising platform for RNA-based therapeutics, ascribed to their excellent stability and prolonged protein translation capacity. However, modulation of circRNA translation remains a great challenge. Here, we develop a new chemically regulated circRNA translation system based on small ligand-induced stabilization of RNA-binding proteins (RBPs). The system is engineered by incorporating RNA motifs into an internal ribosomal entry site and fusing RBPs with small ligand-stabilized conditional proteins. We show that this design allows small ligand-modulated translation of circRNAs with a wide dynamic range and dose dependency. It is demonstrated that this strategy is modular and versatile to different RBPs and small-ligand-stabilized conditional proteins. We further employ this strategy to control the translation of functional proteins, including a guanine nucleotide exchange factor for modulating signaling pathways and a bispecific engager for regulating T cell activities. This system is highly modular and versatile, highlighting its great potential for basic research and therapeutic applications.

View source

Similar papers

Aug 2026

Functional atlas of vertebrate viral RNA elements that stabilize RNA and enhance translation.

Viruses encode diverse regulatory elements, but their breadth and mechanisms remain poorly defined. To address this gap, we performed massively parallel reporter assays spanning ∼200,000 genomic segments from 297 vertebrate-infecting viral genera. We identified numerous viral elements that enhance RNA stability and tra...

Jenny J Seo, Che-Min Lee, Dongbin Lim et al. · 1 citation
Review Open access Aug 2026

RNA‐Binding Proteins: Function, Biological Mechanisms, and Therapeutic Opportunities

A network‐based framework for exploiting RBPs as therapeutic vulnerabilities and for advancing next‐generation precision oncology is provided, integrating mechanistic principles with translational evidence.

Ling Li, Xiu-Li Yan, Qing Ji et al. · 0 citations
Open access Jul 2026

Harnessing natural RNA triplex elements found in lncRNAs MALAT1 and NEAT1 for engineering of novel riboswitch platforms

A novel riboswitch platform based on RNA triplexes stabilizing non-polyadenylated transcripts while still allowing translation of the respective messenger RNA is presented, designed to function independently of nuclear processes such as transcription and RNA processing.

Pierre Gommeringer, Elisabeth Müller, S. Köse et al. · 1 citation
Review Aug 2026

Circular Logic: Engineering Next-Generation Circular RNA Therapeutics for Precision Oncology.

This review argues that circular topology should be viewed as an active pharmacologic variable, not merely a stability enhancement, and dissect recent advances in cap-independent translation initiation, including IRES elements and m6A-driven mechanisms, rolling-circle translation for multi-epitope vaccine design, and p...

Amr A. El-Sehrawy, H. Al-Ameer, J. Rizaev et al. · 0 citations
Open access Jul 2026

Circular Photocaged mRNA for Light-induced Late-stage Activation of Translation.

mRNA is a new medical modality as vaccine and raises hopes to become a protein replacement agent. Despite notable advances in manufacturing, stabilization and modification, its short half-life remains a major limitation. Circular RNA bears potential to solve this issue, as degradation of mRNA proceeds primarily from th...

Bayram Terzi, Greta Charlotte Dahm, Kristoffer Heintz et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.